RESEARCHER PROFILE

Anthony J Lembo

← Back to Case Western Reserve University

A

Case Western Reserve University

Gastrointestinal motility and disordersInflammatory Bowel DiseasePelvic floor disorders treatmentsGut microbiota and healthGastroesophageal reflux and treatments

Anthony J Lembo works in Gastrointestinal motility and disorders, Inflammatory Bowel Disease, Pelvic floor disorders treatments, Gut microbiota and health, Gastroesophageal reflux and treatments. Recorded institutional associations include Beth Israel Deaconess Medical Center, Cleveland Clinic, Harvard University.

605Publications
25,900Citations
79H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Bowel Disorders

    2016 · 2,855 citations
  2. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome

    2008 · 1,194 citations
  3. Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

    2011 · 1,033 citations
  4. Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome

    2010 · 900 citations
  5. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus

    2017 · 852 citations
  6. Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis

    2014 · 751 citations
  7. Development and Validation of the Rome IV Diagnostic Questionnaire for Adults

    2016 · 714 citations
  8. Chronic Constipation

    2003 · 690 citations
  9. American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation

    2014 · 645 citations
  10. American Gastroenterological Association Medical Position Statement on Constipation

    2012 · 519 citations
  11. Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety

    2012 · 464 citations
  12. Effect of Antidepressants and Psychological Therapies, Including Hypnotherapy, in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis

    2014 · 409 citations
  13. Chronic constipation

    2017 · 386 citations
  14. A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation

    2012 · 384 citations
  15. Two Randomized Trials of Linaclotide for Chronic Constipation

    2011 · 376 citations
  16. The Effect of Fiber Supplementation on Irritable Bowel Syndrome: A Systematic Review and Meta-analysis

    2014 · 351 citations
  17. Eluxadoline for Irritable Bowel Syndrome with Diarrhea

    2016 · 328 citations
  18. The international anorectal physiology working group (IAPWG) recommendations: Standardized testing protocol and the London classification for disorders of anorectal function

    2019 · 325 citations
  19. Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome

    2016 · 308 citations
  20. The placebo effect in irritable bowel syndrome trials: a meta‐analysis1

    2005 · 284 citations
  21. Efficacy of Linaclotide for Patients With Chronic Constipation

    2010 · 234 citations
  22. Linaclotide Improves Abdominal Pain and Bowel Habits in a Phase IIb Study of Patients With Irritable Bowel Syndrome With Constipation

    2010 · 230 citations
  23. Severity in Irritable Bowel Syndrome: A Rome Foundation Working Team Report

    2011 · 225 citations
  24. Patient and Practitioner Influences on the Placebo Effect in Irritable Bowel Syndrome

    2009 · 208 citations
  25. Catechol-O-Methyltransferase val158met Polymorphism Predicts Placebo Effect in Irritable Bowel Syndrome

    2012 · 205 citations

← Return to the university profile